Join us for a virtual conference as we introduce the 2021 ACR/VF Vasculitis Clinical Practice Treatment Guidelines to our community. These guidelines represent the first recommendations ever developed and endorsed by the American College of Rheumatology (ACR) and the Vasculitis Foundation (VF) for the management of:

  • Eosinophilic granulomatosis with polyangiitis (EGPA)
  • Giant cell arteritis (GCA)
  • Granulomatosis with polyangiitis (GPA) and Microscopic polyangiitis (MPA)
  • Polyarteritis nodosa (PAN)
  • Takayasu arteritis (TAK)

These recommendations provide guidance regarding the evaluation and management of patients, including diagnostic strategies, use of pharmacologic agents, and surgical interventions.

The conference will start with a general session in the general auditorium for all attendees and then break out into individual disease sessions. After the breakout sessions, attendees will return to the main auditorium for a presentation and brainstorming session discussing the critical importance of disseminating the guidelines to their community rheumatologists, family physicians, nurse practitioners and physician assistants.